Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001975158 | SCV002247384 | pathogenic | Saldino-Mainzer syndrome | 2024-12-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg505*) in the IFT140 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT140 are known to be pathogenic (PMID: 22503633, 23418020, 24009529, 26216056). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with IFT140-related conditions. ClinVar contains an entry for this variant (Variation ID: 1459143). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV003312029 | SCV004010416 | pathogenic | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | IFT140: PVS1, PM2 |
Fulgent Genetics, |
RCV005008310 | SCV005638659 | likely pathogenic | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-06-11 | criteria provided, single submitter | clinical testing |